THRIVE HPV Study
Prospective Studies of Vaginal Mucosal Systems and the Microbiome in Cervical Cancer and HPV Infection
GENDER: Female
HEALTHY PARTICIPANTS: No
CONDITION: Cervical neoplasia (recent abnormal PAP test) & Human Papilloma Virus (HPV) infection
LOCATION: UH Cleveland Medical Center, Midtown, and MacDonald Women’s OB/GYN Ambulatory Clinics
Learn More About This Research Study
To learn more about this study, please call the THRIVE study team at UH at 216-286-6558 or complete the online form below.
Study Purpose
The purpose of this study is to understand how differences in the vaginal microenvironment affect the progression of cervical neoplasia in women infected with the human papilloma virus (HPV). Participants will attend regular clinical sample collection visits approximately every 6 months for 3 years for a total of 7 visits. In addition, participants will complete questionnaires, an online food record tool to collect dietary information prior to the clinical visits, and provide various biosample collections.
Who Can Participate
Participants 18 years old and older with a recent abnormal PAP test or HPV may be eligible for this study.
- STUDY20211043